• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.

作者信息

Maan R, Feld J J, Duarte-Rojo A

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.

Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.

出版信息

Aliment Pharmacol Ther. 2017 Aug;46(3):379-380. doi: 10.1111/apt.14187.

DOI:10.1111/apt.14187
PMID:28677289
Abstract
摘要

相似文献

1
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.社论：丙型肝炎直接抗病毒药物与肾脏——作者回复
Aliment Pharmacol Ther. 2017 Aug;46(3):379-380. doi: 10.1111/apt.14187.
2
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.社论：对于接受无干扰素直接作用抗病毒联合治疗的丙型肝炎患者，预测持续病毒学应答是否需要额外检测？作者回复。
Aliment Pharmacol Ther. 2018 Mar;47(6):849-850. doi: 10.1111/apt.14520.
3
Editorial: good news to patients with thalassaemia-HCV clearance made easy with direct acting antivirals. Authors' reply.社论：地中海贫血患者的好消息——直接作用抗病毒药物使丙型肝炎病毒清除变得容易。作者回复。
Aliment Pharmacol Ther. 2017 Sep;46(6):629-630. doi: 10.1111/apt.14251.
4
Editorial: hepatitis C direct acting anti-viral agents and the kidney.社论：丙型肝炎直接作用抗病毒药物与肾脏
Aliment Pharmacol Ther. 2017 Aug;46(3):378-379. doi: 10.1111/apt.14161.
5
Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C - authors' reply.
Aliment Pharmacol Ther. 2019 Jan;49(1):117-118. doi: 10.1111/apt.15065.
6
Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors' reply.信函：丙型肝炎病毒感染的癌症患者中，直接抗病毒药物是否应与化疗药物联合使用？作者回复。
Aliment Pharmacol Ther. 2017 Mar;45(5):758-759. doi: 10.1111/apt.13937.
7
Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.对帕德马纳班和迪克西特的回复：丙型肝炎病毒进入抑制剂，用于优化基于直接作用抗病毒药物的治疗。
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4527-E4529. doi: 10.1073/pnas.1705234114. Epub 2017 May 16.
8
Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme".回复：“丙型肝炎合并Child's C级肝硬化患者接受直接抗病毒治疗期间的高死亡率：爱尔兰早期获取计划的结果”
J Hepatol. 2016 Aug;65(2):448. doi: 10.1016/j.jhep.2016.04.011. Epub 2016 Apr 27.
9
Editorial: comorbidities, concomitant medications, and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C.社论：慢性丙型肝炎中合并症、伴随用药以及与无干扰素直接抗病毒药物之间潜在的药物相互作用
Aliment Pharmacol Ther. 2019 Jan;49(1):116-117. doi: 10.1111/apt.15051.
10
Editorial: interferon-free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia-Authors' reply.社论：无干扰素直接作用抗病毒药物对丙型肝炎和冷球蛋白血症患者是一大福音——作者回复。
Aliment Pharmacol Ther. 2018 Oct;48(7):772-773. doi: 10.1111/apt.14936.